Questions with the most recent answer or edit.
What I have: WXT · Shanghai Sigma-Audley. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
Conditions: a wine cooler · tirzepatide. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write…
The specifics, since they change the answer: GL Biochem · TFC · the United States. The comparison I want does not seem to exist anywhere in a form I can evaluate. I…
What I have: FGP · Xi’an Mokemei Biotechnology. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
Setup, so nobody has to ask: ERP · KP · New Zealand. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
The specifics, since they change the answer: 98.4% · PeptideMeter · 98.2% · Medutest. The comparison I want does not seem to exist anywhere in a form I can evaluate.…
Conditions: PeptideMeter · 97.1%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
The clinician who ordered the panel was not concerned; I would still like to understand it. This is one of those things that everyone repeats and nobody derives. This…
I got a denial letter that says the requested drug is "not included on the plan's formulary" and separately, further down, that "the plan does not provide benefits…
For reference: 96.4% · ecnoglutide · KP. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
Concretely: SGN · orforglipron. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s interpretation…
Two things I want to understand properly rather than by rule of thumb. First: I keep reading that endotoxin survives autoclaving. Autoclaving is 121 degrees under…
The particulars: TRIUMPH-3 · 4 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
Details up front: 30 mg · 1.5 mL · sterile water for injection. This should be a straightforward calculation and I keep getting two different answers. The numbers are…
What I am working with: racemisation · orforglipron · room temperature. I can predict the outcome but I cannot explain it, which means I will get the next case wrong.…
What I am working with: SURPASS-3 · tirzepatide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Setup, so nobody has to ask: retatrutide · phosphate-buffered diluent. This is a procedural question rather than a theoretical one, and I would like the procedure…
What I am working with: sampling plan · FGP. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
What I am working with: dulaglutide · 2–8 °C. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched…
The specifics, since they change the answer: fibrillation · ecnoglutide · 40 °C. I understand the observation; what I do not understand is the mechanism behind it. I…
Details up front: a GLP-1 receptor agonist · six weeks · minus 20 °C. This is a planning question. I know what my options are; I do not know how to weigh them. What I…
I have been through one internal appeal already and would like to do the next one properly. I can find plenty of assertions about this and almost no reasoning, which…
The particulars: tirzepatide · 2.5 mg/mL. I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.…
The case in front of me: liraglutide · Shanghai. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…